Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
1
HSA:1
Drug Approvals
NUVAXOVID DISPERSION FOR INJECTION COVID-19 VACCINE 5 mcg/dose (RECOMBINANT, ADJUVANTED) IN SDV
- Approval Date
- Dec 16, 2024
HSA
Clinical Trials
No trials found
News
No news found